Eledon Pharmaceuticals (ELDN) Depreciation & Amortization (CF) (2016 - 2020)

Eledon Pharmaceuticals (ELDN) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $1000.0 in Q3 2020.

• Quarterly Depreciation & Amortization (CF) fell 66.67% year-over-year to $1000.0 in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $1000.0 (down 88.89% YoY) and the FY2020 annual result came in at $5000.0, down 44.44% from the prior year.
• Depreciation & Amortization (CF) slipped to $1000.0 in Q3 2020, from $2000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $53000.0 in Q1 2016 to a low of -$4000.0 in Q3 2016.
• A 5-year average of $8789.5 and a median of $3000.0 in 2018 frame the typical range for Depreciation & Amortization (CF).
• The widest YoY moves for Depreciation & Amortization (CF): up 960.0% in 2016, down 112.5% in 2016.
• Tracing ELDN's Depreciation & Amortization (CF) over 5 years: stood at $19000.0 in 2016, then slumped by 78.95% to $4000.0 in 2017, then retreated by 25.0% to $3000.0 in 2018, then plunged by 33.33% to $2000.0 in 2019, then slumped by 50.0% to $1000.0 in 2020.
• The last three Depreciation & Amortization (CF) figures came in at $1000.0 (Q3 2020), $2000.0 (Q2 2020), and $2000.0 (Q1 2020), per Business Quant data.